Angiotensin II Blockade Augments Renal Cortical Microvascular pO2 Indicating a Novel, Potentially Renoprotective Action

Publisher： Karger

ISSN： 1660-2137

Source： Nephron Physiology, Vol.94, Iss.2, 2003-07, pp. : p39-p46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Forskolin Derivative, Colforsin Daropate Hydrochloride, Inhibits the Decrease in Cortical Renal Blood Flow Induced by Noradrenaline or Angiotensin II in Anesthetized Rats

By  

Nephron Physiology, Vol. 96, Iss. 2, 2004-02 ,pp. : p59-p64

Karger

Access to resources Recommend Favorite

Angiotensin II Regulation of Renal Dopamine Uptake and Na+,K+-ATPase Activity

By  

Nephron Physiology, Vol. 111, Iss. 4, 2009-03 ,pp. : p55-p60

Karger

Access to resources Recommend Favorite

Effects of Angiotensin II on Renal Dopamine Metabolism: Synthesis, Release, Catabolism and Turnover

By  

Nephron Physiology, Vol. 115, Iss. 1, 2010-04 ,pp. : p1-p7

Karger

Access to resources Recommend Favorite

Effect of Angiotensin II Type 1 Receptor Blockade on Conduit Artery Tone in Subtotally Nephrectomized Rats

By  

Nephron Physiology, Vol. 96, Iss. 3, 2004-03 ,pp. : p91-p98

Karger

Access to resources Recommend Favorite

Iron Dextran Causes Renal Iron Deposition but Not Renal Dysfunction in Angiotensin II-Treated and Untreated Rats

By  

Nephron Physiology, Vol. 98, Iss. 4, 2004-12 ,pp. : p107-p113

Karger

Access to resources Recommend Favorite